Sign In

Christian Scherrer

Growth Investor at Kinnevik

Professional Background

Christian Scherrer has established himself as a leading figure in healthcare investment since joining Kinnevik in 2014. His journey began at JP Morgan, where he honed his skills in technology and media investment banking, providing him with a robust foundation in the financial sector. At Kinnevik's London office, he took on the ambitious challenge of building a healthcare portfolio that has now evolved into a substantial segment of the company’s asset base, accounting for over a third of Kinnevik's total investments.

With a strategic approach, Christian is credited with crafting and executing Kinnevik’s healthcare strategy, an endeavor that involved nearly USD 1 billion in investments across various healthcare services and technology companies in both the US and Europe. His forward-thinking investment strategies have led to successful entries into notable companies such as Livongo, VillageMD, and Cedar, to name a few, where he has made early investments that propelled the companies to significant growth and subsequent acquisitions.

Christian has also been instrumental in leading Kinnevik's foray into the biotech sector. His leadership was highlighted by a significant PIPE investment in Recursion (RXRX), along with a private investment in Enveda Biosciences, showcasing his ability to identify and capitalize on future trends in healthcare and biotechnology.

Education and Achievements

Christian's academic background laid the groundwork for his impressive career in finance and investment. He earned his MSc in Finance from the prestigious Imperial College London, where he gained a comprehensive understanding of financial markets and investment strategies. Prior to that, he completed a BA in Economics and Business Administration at the University of Zurich, further enriching his expertise in economics, finance, and business management.

Leadership and Board Involvement

Throughout his career, Christian has assumed various leadership roles within the organizations he has been associated with. His tenure as a Board Member at Enveda Biosciences, Spring Health, and Pelago (formerly Quit Genius) reflects his influence in shaping the strategic direction of these companies. Additionally, his role as a Board Observer at Transcarent and Cityblock Health demonstrates his commitment to supporting innovative healthcare solutions and enhancing patient outcomes.

His experience as a Senior Investment Director at Kinnevik AB further highlights his deep involvement in investment decision-making processes, strategic planning, and portfolio management. As he continues to drive Kinnevik's ambitious healthcare goals, Christian remains a pivotal leader navigating the complexities of the ever-evolving healthcare landscape.

In summary, Christian Scherrer is not only a seasoned investment banker with a keen eye for growth opportunities in healthcare but also a thought leader advocating for enhanced healthcare services through technology and innovation. His strategic foresight and commitment to creating impactful investments have positioned him as one of the influential figures in the healthcare investment sector today.

Related Questions

How did Christian Scherrer develop his expertise in healthcare investments at Kinnevik?
What strategies did Christian Scherrer implement to grow Kinnevik's healthcare portfolio significantly?
What insights can Christian Scherrer share about investing in biotechnology companies?
How did Christian Scherrer identify promising healthcare companies like Livongo and VillageMD for investment?
What challenges has Christian Scherrer faced in building a healthcare investment strategy at Kinnevik?
Christian Scherrer
Add to my network

Location

Greater London, England, United Kingdom